Dr. David I. Lee, MD

Dr. Lee practices at UCI Health - Orange in Orange, California, part of UC Irvine.

Dr. Lee's NPI, 1730128232, was assigned on June 6, 2006. Dr. Lee graduated from Loma Linda University School Of Medicine in 1995. Dr. Lee holds California license A79592.

Dr. Lee's primary practice is UCI Health - Orange, at 101 City Drive South, Orange, CA 92868 in Orange County. The practice phone is (714) 456-7890.

Dr. Lee's primary practice is UCI Health - Orange in Orange, California, part of UC Irvine. Dr. Lee is also affiliated with Penn Presbyterian Medical Center. The medical group on file is UCI Health Center for Urological Care. Dmand AI also links Dr. Lee to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lee practices, 2 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Lee's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Lee is board certified in urology by the American Board of Urology. Dmand AI has Dr. Lee's licenses on file in 5 states: California, Pennsylvania, Nevada, New Jersey and Texas.

Dmand AI lists enlarged prostate, erectile dysfunction, prostate cancer, prostate surgery, testicular dysfunction, urine flow blockage and UTI among the conditions Dr. Lee treats.

CMS data shows 811 Medicare services from Dr. Lee across 10 procedure codes in 2024, for 367 Medicare patients. Medicare paid $144,076 for them.

CMS counts 367 Medicare patients who saw Dr. Lee in 2024. The largest group is 65 to 74, with 214 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.09, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lee's median patient age at 69, with 3% women.

In 2024, Dr. Lee wrote 108 Medicare Part D claims for 44 patients. 98% of them were for generic drugs. CMS names the drug for 79 of them, across 2 drugs with 11 or more claims each, at $1,158 in total drug cost. In 2023, CMS named 115 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Lee for performance year 2024, reported through an alternative payment model (APM). Dr. Lee accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lee as offering telehealth. CMS counts 54 procedures of prostate resection by Dr. Lee, more than 97% of the clinicians it reports for that procedure.

Hernia repair (minimally invasive): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 160 papers to Dr. Lee, published from 2004 to 2025. 2019 was the busiest year, with 11. The most frequent topics are Prostatectomy, Prostatic Neoplasms and Robotics. Dr. Lee has published most often in J Endourol. Dr. Lee's most frequent co-authors are Ralph V. Clayman, MD, Mohammed Darwish Shahait, MBBS and Jaime Landman, MD.

CMS Open Payments shows 108 general payments to Dr. Lee from 15 drug and device companies from 2016 to 2025. Education make up the largest share, 36% of the total. Intuitive Surgical, Inc. paid the most, $19,392.

Dmand AI lists 5 awards for Dr. Lee, most recently Philadelphia Magazine in 2014.

Dr. Lee graduated from Loma Linda University School Of Medicine in 1995. Dr. Lee is a member of ACS, ASCO, AUA, Endourological Society, SLS and Society of Robotic Surgeons.

Dr. Lee is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.